🚀 Unlock the Future of CNS Drug Discovery with Pharmidex 🧠
August 28, 2024
At
Pharmidex, we're dedicated to advancing the frontier of Central Nervous System (CNS) drug discovery. With our deep expertise in
in vitro and
in vivo models, DMPK studies, and translational science, we provide end-to-end solutions that accelerate your CNS projects from concept to clinic.
🔬 Our CNS services include:
- In vitro assays for neurotoxicity, neuroprotection, and receptor binding.
- In vivo models for a wide range of CNS disorders including
neurodegeneration, psychiatric disorders, and pain. - DMPK studies with a focus on CNS penetration, blood-brain barrier
studies, and more. - Expert consultancy to optimize your CNS drug development strategy.
Partner with us to bring innovative therapies to patients faster. Let's collaborate and make breakthroughs in CNS research together!
🌐 Explore our CNS services:
https://www.pharmidex.com/CNS
#CNS #Neuroscience #DrugDiscovery #Pharmidex #LifeSciences #Neuropharmacology #DMPK #TranslationalResearch #Biotech #Pharma
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩🔬 👨🔬 Welcome to the team, Gabrielle and Mohammed!
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: ✅ Bitter-tasting APIs ✅ Unpalatable excipients ✅ The success of taste-masking strategies ✅ Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
